Covidien Stock Price (NYSE:COV)

Add to My Stocks
$106.71 $1.36 (1.26%) COV stock closing price Jan 26, 2015 (Closing)
Prev Close* : $108.07
Market Cap:
Day Low: $106.71
52 Week Low: $65.97
Open: $107.97
Volume: 24887138
Day High: $108.16
52 Week High: $108.57

Latest Stock Market News

Latest Articles

Covidien News - From Partners

COV Stockcharts

View COV PE ratio, PS ratio stocks charts and compare with peers.
COV Chart
Note: Compare Covidien stock price history with the index and industry peers.

COV Industry Peers

Company Price Change (%)
Abbott (ABT)52.610.1 (0.19%)
Stryker (SYK)140.140.75 (0.53%)
Becton Dickinson (BDX)193.20.14 (0.07%)
C.r. Bard (BCR)318.50.13 (0.04%)
Baxter International (BAX)62.760.75 (1.18%)
Johnson & Johnson (JNJ)131.170.22 (0.17%)
Boston Scientific (BSX)28.750.1 (0.35%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
VERU INC (VERU)2.320.15 (6.91%)
Rockwell Medical (RMTI)7.610.23 (3.12%)
Cerus (CERS)2.680.08 (3.08%)
OraSure (OSUR)22.140.4 (1.84%)
Omeros (OMER)21.260.38 (1.82%)
MacroGenics (MGNX)17.330.28 (1.64%)
NuVasive (NUVA)55.060.81 (1.49%)
Top gainers from Medical Products industry
* As of Sep 26, 2017
CompanyPriceChange (%)
Fonar (FONR)28.80.9 (3.03%)
ICU Medical (ICUI)181.353.55 (1.92%)
Medtronic (MDT)78.271.43 (1.79%)
Bio-Rad Laboratories (BIO)225.373.31 (1.45%)
Trinity Biotech (TRIB)5.480.08 (1.44%)
Enzymotec (ENZY)11.150.15 (1.33%)
Baxter International (BAX)62.760.75 (1.18%)
Top losers from Medical Products industry
* As of Sep 26, 2017

Covidien plc Stock News - Partner Headlines

David Abrams' recent trades   on Feb 23, 2015

Covidien Financial Statements

income statement20142013201220112010
Net Sales or Revenues10.66B10.24B11.85B11.57B10.43B
Net Income1.66B1.7B1.91B1.87B1.63B
Total Operating Expense4.34B3.95B4.4B4.2B3.74B
View Covidien income statement
balance sheet20142013201220112010
Total Assets20.7B19.92B22.26B20.37B20.39B
Total Liabilities10.64B10.68B11.69B10.56B11.41B
Shareholders Equity10.06B9.24B10.57B9.82B8.97B
View Covidien balance sheet
cash flow statement20142013201220112010
Net Increase (Decrease) in Assets Liabilities-253M-343M-232M-551M97M
Net Cash from (used by) Operating Activities2.01B2.1B2.43B2.18B2.19B
Increase (Decrease) in Prop Plant And Equipment-353M-482M-526M-467M-401M
View Covidien cash flow statement

Covidien Stock Message Board

As of last trading day, Covidien stock price was 106.71. The total market value as denoted by 48.5B for Covidien, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Covidien valuation, even though in the short-term sentiment and current breaking news might affect Covidien stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Covidien is worth a lot, it will most likely be reflected in an inflated Covidien stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 24887138 COV shares were traded yesterday, and Covidien stock chart shows that the COV stock quote hit a day high of 108.16 and day low of 106.71. Covidien paid 1.44 stock dividends to its shareholders during last quarter. Covidien stock price history, gives the entire historical data for COV stock.